Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Jun 02, 2023 12:25pm

124 Views

Post# 35477107

LABS in conjunction with McMaster University (Degroote

School of Medicine) currently have research/clinical trial within this scope. Keep in mind, the disease is an 'autoimmune' system disease and the immune system responds to endocannabinoid receptors when exposed to cannabinoid compounds.

This health problem is actually accelerating within our species.

https://www.ctvnews.ca/health/experts-warn-of-rapid-growth-of-ibd-as-number-of-canadians-diagnosed-set-to-reach-470k-by-2035-1.6423885

Crohn's and Colitis Canada says IBD describes a group of conditions the two main forms of which are Crohn's disease and ulcerative colitis. These autoimmune diseases cause inflammation, ulcers, and bleeding in the bowel that can extend to the rest of the body.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (April 26, 2024)